RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Results of Aspirin as a primary prevention strategy: cardiovascular & bleeding events https://t.co/lllS2mG24M
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @d_ast777: Dr...so I guess there goes the idea that one bayer aspirin a day prevents heart attacks https://t.co/F9SOOcJwGJ
CV = CARDIOVASCULAR
RT @Bloodman: Another trial showing no role for ASA in primary prevention in the current era of statins and other risk factor reduction htt…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
Использование аспирина для первичной профилактики сердечно-сосудистых осложнений у пожилых людей приводит к значительному повышению рисков серьезных кровотечений и не обеспечивает значимой профилактики сосудистых катастроф
RT @A_SisoAlmirall: The use of low-dose aspirin as a Primary Prevention strategy in Older adults resulted in a significantly higher risk of…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @Curseen: The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major…
A significantly higher risk of major hemorrhage with same cardiovascular risk! Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/BUVoRV5z2r
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @aakonc: Bleeding rates w aspirin are consistently underestimated, I blame the "baby" nomenclature which makes it sound so innocuous htt…
RT @connors_md: an excellent study answering a question from patients that comes up all the time--should I take aspirin? Effect of Aspirin…
RT @ahakawi: ضرر الأسبرين يفوق منافعه لدى كبار السن الأصحاء في دراسة حديثة شملت أكثر من ١٩ ألف شخص https://t.co/LFpbkdQwOg
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
Dr...so I guess there goes the idea that one bayer aspirin a day prevents heart attacks
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/ZWwbavOGni
Lovely study from a great group of statisticians and others at Monash University.
RT @A_SisoAlmirall: The use of low-dose aspirin as a Primary Prevention strategy in Older adults resulted in a significantly higher risk of…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
ضرر الأسبرين يفوق منافعه لدى كبار السن الأصحاء في دراسة حديثة شملت أكثر من ١٩ ألف شخص
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the Healthy Elderly | NEJM https://t.co/Ja3hUEMdpW
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @cardielmh: Are we ready to change our practice? Quite interesting study https://t.co/AW6B5Ryz3o
https://t.co/e3LxcU1xDx Ok, so what do we do with people who have been on Aspirin for many years with no haemmorrhage? They persumably now a self selected subgroup ( perhaps initial lower risk for SE) and it may be that for them there is a differnt risk/be
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @drjasondungu: Really need to rethink primary prevention strategies in the elderly, in whom prognostic benefit is doubtful for most inte…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Here are the papers: #1 CV events & bleeding: https://t.co/cIPBn5uCrv
RT @emas_online: Effect of #Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly: study in 20,000 people showed low-dose as…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @A_SisoAlmirall: The use of low-dose aspirin as a Primary Prevention strategy in Older adults resulted in a significantly higher risk of…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @Bloodman: Another trial showing no role for ASA in primary prevention in the current era of statins and other risk factor reduction htt…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @drjasondungu: Really need to rethink primary prevention strategies in the elderly, in whom prognostic benefit is doubtful for most inte…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @Ramipril_: Prevención sin límites. El ácido acetilsalicílico en dosis bajas, como estrategia de prevención primaria en ancianos no esta…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @martinezvelilla: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/ddtMSEvmaF
RT @Bloodman: Another trial showing no role for ASA in primary prevention in the current era of statins and other risk factor reduction htt…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @pauldub67: A pivotal moment in primary prevention ? @mmamas1973 @DrPascalMeier @sbrugaletta @hect2701 @PCRonline @EuroInterventio @Cath…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @Bloodman: Another trial showing no role for ASA in primary prevention in the current era of statins and other risk factor reduction htt…
RT @drjasondungu: Really need to rethink primary prevention strategies in the elderly, in whom prognostic benefit is doubtful for most inte…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento crónico añadida una "aspirinita infantil para la circulación" ? Suena a poco pero hay muchos y tiene consecuencias #SegPac
A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo showed - similar CVD events - higher bleeding - similar disability-free survival - higher allcause mortality (!) in pats on aspiri
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @connors_md: an excellent study answering a question from patients that comes up all the time--should I take aspirin? Effect of Aspirin…